Promising medication given before surgery could improve surgical outcomes and reduce healthcare burdens associated with obesity.

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Texas AG sues Eli Lilly for bribery related to prescribing GLP-1 meds for weight loss and diabetes, alleging unethical inducements to medical providers.

Cardiology is undergoing a year of rapid change, driven by innovations that are expanding diagnostic capabilities, advancing treatment options and personalizing care. From artificial intelligence and ...

Texas Attorney General Ken Paxton is accusing Eli Lilly and Co. of a kickback scheme to induce medical providers to prescribe ...

In June 2025, Fractyl presented preclinical data at the American Diabetes Association’s 85th Scientific Sessions that showed ...

The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...

Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...